Loblaw Companies Limited · TSX:L
Loblaw Companies — Q1 2016 Earnings Presentation
6 slides from Loblaw Companies's earnings presentation, May 4, 2016
Slide 1: Q1 2016 Supplementary Slides
Q1 2016 Supplementary Slides May 4, 2016 1
Slide 2: Forward-looking Statements
Forward-looking Statements This presentation for Loblaw Companies Limited (“Loblaw” or “the Company”) contains forward-looking statements about the Company’s objectives, plans, goals, aspirations, strategies, financial condition, results of operations, cash flows, performance, prospects, opportuniti
Slide 3: Key Financial Metrics – Loblaw – Q1 2016
Key Financial Metrics – Loblaw – Q1 2016 Consolidated Revenue $10,381M,+3.3% Adjusted EBITDA $829M, +5.1% Adjusted Diluted Earnings Per Common Share $0.82, +13.9% Net Synergies $72M, incremental $28M Free Cash Flow $512M QTD Capex ($) $157M QTD 3
Slide 4: Key Retail Metrics – Q1 2016
Key Retail Metrics – Q1 2016 Total Retail Revenue $10,154M, +3.3% Retail Revenue - Food Retail $7,390M,+2.2% Retail Revenue - Drug Retail $2,764M,+6.5% Retail Adjusted Gross Profit & Margin $ 2,718M; +26.9% (+20bps to PY) (Excluding the impact of the consolidation of franchises) (As Reported: $2,777
Slide 5: Key Operational Metrics – Q1 2016 – Loblaw
Key Operational Metrics – Q1 2016 —Loblaw Food Retail Same-Store Sales Growth +2.6% (ex Gas Bar (60bps)); including Gas Bar, Food Retail SSS was +2.0%) Basket Size Increased Traffic Positive Internal Inflation Loblaw moderately higher than Q1 Food CPI of 4.3% Loblaw STM Square Footage Growth - 0.8%
Slide 6: Key Operational Metrics – Q1 2016 – Shoppers Drug Mart
Key Operational Metrics – Q1 2016 Shoppers Drug Mart Pharmacy Sales $1,313 M, +4.5% Pharmacy SSS +4.2% # Rx Dispensed (Rx Count) +4.1% (+3.9% on same-store sales basis) Average Rx Value +0.6% Front Store Sales $1,451 M, + 8.4% Front Store SSS +8.2% Loyalty (Optimum) Over 10 million active members 6